Rapid Diagnostics Market Expected to Grow at 12.5% CAGR Through 2029: Industry Forecast

 Get 20% Off Market Intelligence Reports With Code ONLINE20 — Track Global Tariffs, Economic Shifts, and Sector Transformations

 

 What Is the Current Market Size and Growth Rate of the Rapid Diagnostics Market?
 The rapid diagnostics market size has grown rapidly in recent years. It will grow from $32.01 billion in 2024 to $36.08 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increasing prevalence of infectious diseases, rising demand for point-of-care testing, rise in antimicrobial resistance, increasing awareness of early disease detection, and rising healthcare expenditure in emerging markets.
 
 The rapid diagnostics market size is expected to see rapid growth in the next few years. It will grow to $57.71 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to growing adoption of personalized medicine, increasing integration of ai in diagnostics, rising demand for home-based testing kits, growing investments in healthcare infrastructure, and increasing focus on pandemic preparedness. Major trends in the forecast period include advancement in microfluidics technology, innovation in biosensor-based diagnostics, integration of smartphone apps with diagnostic tools, advancement in lab-on-a-chip systems, and innovation in multiplexed testing platforms.
 
 Claim your free report sample now:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=24679&type=smp
 
 Who Are the Major Contributors to the Rapid Diagnostics Market Growth?
 The increasing prevalence of infectious disease is expected to propel the growth of the rapid diagnostics market going forward. Infectious disease refers to illnesses caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi, which can be spread directly or indirectly from one person to another. The rise in prevalence of infectious diseases is driven by increased global travel, which contribute to faster transmission and higher infection rates. Rapid diagnostics help infectious diseases by enabling quick and accurate identification of pathogens, allowing for timely treatment decisions, reduced transmission, and improved patient outcomes. For instance, in May 2025, according to the The World Health Organization (WHO), Switzerland-based specialized agency of the United Nations responsible for international public health, since mid-February 2025, global SARS-CoV-2 (the virus responsible for causing COVID-19, an infectious disease)activity has been on the rise, based on data from sentinel sites, with the test positivity rate reaching 11%, a level last observed in July 2024. Therefore, the increasing prevalence of infectious disease are driving the rapid diagnostics market.
 
 How Is the Rapid Diagnostics Market Divided by Type and Application?
 The rapid diagnostics market covered in this report is segmented — 
 
 1) By Product Type: Kits, Reagents, Instruments, Other Product Types
 2) By Platform: Immunoassays, Molecular Detection, Other Rapid Diagnostic Platforms
 3) By Application: Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy and Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing
 4) By Distribution Channel: Hospital Pharmacies, Brick and Mortar, E-Commerce, Other Distribution Channels
 5) By End Use: Diagnostic Centers, Homecare Settings, Hospital Pharmacies, Other End Users
 
 Subsegments:
 1) By Kits: Lateral Flow Assay Kits, PCR Kits, Immunoassay Kits, Microfluidic Kits, Molecular Diagnostic Kits, Multiplex Kits
 2) By Reagents: Enzymes, Buffers, Probes and Primers, Stains and Dyes, Antibodies, Calibration and Control Reagents
 3) By Instruments: PCR Machines, Lateral Flow Readers, Immunoassay Analyzers, Microfluidic Analyzers, Automated Sample Processors, Biosensors
 4) By Other Product Types: Software and Data Management Tools, Sample Collection Devices, Accessories and Consumables, Calibration Standards, Point-of-Care Devices
 
 What Are the Significant Trends in the Rapid Diagnostics Market Across Regions?
 Major companies operating in the rapid diagnostics market are focusing on advancements and innovation, such as rapid diagnostic testing tools, to enhance diagnostic accuracy, reduce turnaround times, and improve patient outcomes in point-of-care settings. Rapid diagnostic testing tools refer to medical devices that quickly detect the presence of specific diseases or conditions, typically providing results within minutes at the point of care. For instance, in May 2025, SEKISUI Diagnostics a US-based medical diagnostics manufacturer, launched the OSOM RSV Test, a rapid diagnostic tool for detecting respiratory syncytial virus (RSV). This test is intended for use in professional healthcare settings and delivers results in just 15 minutes. It employs a rapid immunochromatographic assay to qualitatively detect RSV nucleoprotein antigen. The test uses anterior nasal swab specimens collected from patients showing symptoms of respiratory infection. Its quick turnaround time supports timely and effective clinical decision-making.
 
 Who Are the Emerging Players in the Rapid Diagnostics Market?
 Major companies operating in the rapid diagnostics market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux S.A., QuidelOrtho Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., OraSure Technologies Inc., Nova Biomedical Corporation, Fujirebio Holdings Inc., Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Abingdon Health plc, Abionic SA 
 
 Get the full rapid diagnostics market report here:
 https://www.thebusinessresearchcompany.com/report/rapid-diagnostics-global-market-report
 
 How Is Regional Performance Expected to Affect Rapid Diagnostics Market Growth?
 North America was the largest region in the rapid diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rapid diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company